Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC ...
Your time is up, you little shit, I thought. I was going to kill this thing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results